Page 205 - Remedial Andrology

722. Lee, W.K., et al. - Can estimated intravaginal ejaculatory latency time be used interchangeably with
stopwatch-measured intravaginal ejaculatory latency time for the diagnosis of lifelong premature
ejaculation? Urology. 85(2):375 80, 2015 Feb., 2015.
https://pubmed.ncbi.nlm.nih.gov/25623693
723. Waldinger, M.D., et al. Geometric mean IELT and premature ejaculation: appropriate statistics to
avoid overestimation of treatment efficacy. J Sex Med, 2008. 5: 492.
https://pubmed.ncbi.nlm.nih.gov/18179458
724. Symonds, T., et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol,
2007. 52: 565.
https://pubmed.ncbi.nlm.nih.gov/17275165
725. Arafa, M., et al. Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE).
J Sex Med, 2007. 4: 1750.
https://pubmed.ncbi.nlm.nih.gov/17970977
726. Althof, S., et al. Development and validation of a new questionnaire to assess sexual satisfaction,
control, and distress associated with premature ejaculation. J Sex Med, 2006. 3: 465.
https://pubmed.ncbi.nlm.nih.gov/16681472
727. Rosen, R.C., et al. Development and validation of four-item version of Male Sexual Health
Questionnaire to assess ejaculatory dysfunction. Urology, 2007. 69: 805.
https://pubmed.ncbi.nlm.nih.gov/17482908
728. Althof, S.E. Psychosexual therapy for premature ejaculation. Transl Androl Urol, 2016. 5: 475.
https://pubmed.ncbi.nlm.nih.gov/27652220
729. Cormio, L., et al. The Combination of Dapoxetine and Behavioral Treatment Provides Better Results
than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation. J Sex
Med, 2015. 12: 1609.
https://pubmed.ncbi.nlm.nih.gov/26077706
730. Pavone, C., et al. Premature ejaculation: Pharmacotherapy vs group psychotherapy alone or in
combination. Arch Ital Urol Androl, 2017. 89: 114.
https://pubmed.ncbi.nlm.nih.gov/28679182
731. Melnik, T., et al. Psychosocial interventions for premature ejaculation. Cochrane Database Syst Rev,
2011: Cd008195.
https://pubmed.ncbi.nlm.nih.gov/21833964
732. Porst, H., et al. Baseline characteristics and treatment outcomes for men with acquired or lifelong
premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3
dapoxetine trials. J Sex Med, 2010. 7: 2231.
https://pubmed.ncbi.nlm.nih.gov/20412423
733. EMA. Fortacin: Summary of product characteristics. 2014.
https://www.ema.europa.eu/en/documents/product-information/fortacin-epar-product-information_
en.pdf
734. Pryor, J.L., et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an
integrated analysis of two double-blind, randomised controlled trials. Lancet, 2006. 368: 929.
https://pubmed.ncbi.nlm.nih.gov/16962882
735. Qin, Z., et al. Safety and efficacy characteristics of oral drugs in patients with premature ejaculation:
a Bayesian network meta-analysis of randomized controlled trials. Int J Impot Res, 2019.
https://pubmed.ncbi.nlm.nih.gov/31024113
736. Jian, Z., et al. Pharmacotherapy of premature ejaculation: a systematic review and network meta-
analysis. Int Urol Nephrol, 2018. 50: 1939.
https://pubmed.ncbi.nlm.nih.gov/30225547
737. Sridharan, K., et al. Pharmacological interventions for premature ejaculation: a mixed-treatment
comparison network meta-analysis of randomized clinical trials. Int J Impot Res, 2018. 30: 215.
https://pubmed.ncbi.nlm.nih.gov/29921893
738. Castiglione, F., et al. Current Pharmacological Management of Premature Ejaculation: A Systematic
Review and Meta-analysis. Eur Urol, 2016. 69: 904.
https://pubmed.ncbi.nlm.nih.gov/26749092
739. Lue, T.F., et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med, 2004.
1: 6.
https://pubmed.ncbi.nlm.nih.gov/16422979
740. Rowland, D.L., et al. Attribution Patterns in Men Who Ejaculate Before They Desire: An Internet
Survey. J Sex Marital Ther, 2016. 42: 462.
https://pubmed.ncbi.nlm.nih.gov/26168349

204 SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021